Ole Kristian Hejlesen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ole Kristian Hejlesen has a total of 320 co-authors. Here are the top co-authors by number of shared publications:
- Morten Hasselstrøm Jensen
Department of Health Science and Technology Aalborg University Aalborg Denmark
29 shared publications - Simon Lebech Cichosz
Aalborg University
24 shared publications - Stine Hangaard
Department of Health Science and Technology, Aalborg University, Denmark
22 shared publications - Mette Dencker Johansen
Department of Health Science and Technology, Aalborg University, Denmark
19 shared publications - Flemming Witt Udsen
Aalborg University
17 shared publications - Thomas Kronborg
Department of Health Science and Technology, Aalborg University, Denmark
15 shared publications
Latest Publications
- Open Access
- 6 May 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e85384
General Practitioners and Pharmacists’ Perspectives on Electronic Prescribing for Multidose Drug Dispensing: Mixed Methods Study
Background: Medication safety remains a significant challenge in health care, particularly for patients managing complex treatment regimens. In Norway, the introduction of electronic prescribing (e-prescribing) for multidose drug dispensing (eMDD) aims to improve medication adherence and minimize errors by seamlessly integrating with the national e-prescription infrastructure. Objective: This study aimed to investigate the challenges faced by general practitioners (GPs) and pharmacists in using eMDD in Norway. Additionally, it sought to gather their recommendations for system improvements to guide future development and nationwide implementation. Methods: A parallel mixed methods design was used, integrating both quantitative and qualitative data. A structured online survey was distributed to 54 pharmacies and 190 GP surgeries across Norway. The survey included a combination of multiple-choice and open-ended questions. Qualitative responses were analyzed thematically using NVivo, while quantitative data were processed using the built-in analytical tools in Nettskjema. Results: A total of 70 health care professionals participated in the study, revealing 7 key themes: training, system and technology, communication and interaction, division of responsibilities, medication safety, time and resource use, and implementation challenges. GPs reported inadequate training and an overwhelming volume of communication, while pharmacists identified issues with system integration and unclear role definitions. Both groups emphasized the need for improved system usability, stronger interprofessional collaboration, and a more defined governance structure. Conclusions: While the eMDD system has the potential to improve medication safety and optimize workflows, its success depends on addressing technical inefficiencies, improving user training, and clarifying role responsibilities. Actively involving end users in system development and policy planning is critical for achieving effective national implementation and ensuring integration with broader eHealth initiatives, such as the Patient’s Medication List.
- 6 May 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e85384
Open AccessGeneral Practitioners and Pharmacists’ Perspectives on Electronic Prescribing for Multidose Drug Dispensing: Mixed Methods Study
Background: Medication safety remains a significant challenge in health care, particularly for patients managing complex treatment regimens. In Norway, the introduction of electronic prescribing (e-prescribing) for multidose drug dispensing (eMDD) aims to improve medication adherence and minimize errors by seamlessly integrating with the national e-prescription infrastructure. Objective: This study aimed to investigate the challenges faced by general practitioners (GPs) and pharmacists in using eMDD in Norway. Additionally, it sought to gather their recommendations for system improvements to guide future development and nationwide implementation. Methods: A parallel mixed methods design was used, integrating both quantitative and qualitative data. A structured online survey was distributed to 54 pharmacies and 190 GP surgeries across Norway. The survey included a combination of multiple-choice and open-ended questions. Qualitative responses were analyzed thematically using NVivo, while quantitative data were processed using the built-in analytical tools in Nettskjema. Results: A total of 70 health care professionals participated in the study, revealing 7 key themes: training, system and technology, communication and interaction, division of responsibilities, medication safety, time and resource use, and implementation challenges. GPs reported inadequate training and an overwhelming volume of communication, while pharmacists identified issues with system integration and unclear role definitions. Both groups emphasized the need for improved system usability, stronger interprofessional collaboration, and a more defined governance structure. Conclusions: While the eMDD system has the potential to improve medication safety and optimize workflows, its success depends on addressing technical inefficiencies, improving user training, and clarifying role responsibilities. Actively involving end users in system development and policy planning is critical for achieving effective national implementation and ensuring integration with broader eHealth initiatives, such as the Patient’s Medication List.
- Open Access
- 14 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
General Practitioners and Pharmacists Perspectives on Electronic Prescribing for Multidose Drug Dispensing: Mixed Methods Study (Preprint)
BACKGROUND Medication safety remains a significant challenge in healthcare, particularly for patients managing complex treatment regimens. In Norway, the introduction of the electronic prescribing (e-prescribing) for multidose drug dispensing aims to improve medication adherence and minimize errors by seamlessly integrating with the national e-prescription infrastructure. OBJECTIVE This study aimed to investigate the challenges faced by general practitioners and pharmacists in using e-prescribing for multidose drug dispensing in Norway. Additionally, it sought to gather their recommendations for system improvements to guide future development and nationwide implementation. METHODS A parallel mixed methods design was used, integrating both quantitative and qualitative data. A structured online survey was distributed to 54 pharmacies and 190 General Practitioner (GP) surgeries across Norway. The survey included a combination of multiple-choice and open-ended questions. Qualitative responses were analyzed thematically using NVivo, while quantitative data were processed using the built-in analytical tools in Nettskjema.no. RESULTS A total of seventy healthcare professionals participated in the study, revealing seven key themes: training, system and technology, communication and interaction, division of responsibilities, patient safety, time and resource use, and implementation challenges. General Practitioners reported inadequate training and an overwhelming volume of communication, while pharmacists identified issues with system integration and unclear role definitions. Both groups emphasized the need for improved system usability, stronger interprofessional collaboration, and more defined governance structure. CONCLUSIONS While the e-prescribing for multidose drug dispensing system has the potential to improve medication safety and optimized workflows, its success depends on addressing technical inefficiencies, improving user training, and clarifying role responsibilities. Actively involving end users in system development and policy planning is critical for achieving effective national implementation and ensuring integration with broader e-health initiatives, such as the Patient’s Medication List.
- 14 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessGeneral Practitioners and Pharmacists Perspectives on Electronic Prescribing for Multidose Drug Dispensing: Mixed Methods Study (Preprint)
BACKGROUND Medication safety remains a significant challenge in healthcare, particularly for patients managing complex treatment regimens. In Norway, the introduction of the electronic prescribing (e-prescribing) for multidose drug dispensing aims to improve medication adherence and minimize errors by seamlessly integrating with the national e-prescription infrastructure. OBJECTIVE This study aimed to investigate the challenges faced by general practitioners and pharmacists in using e-prescribing for multidose drug dispensing in Norway. Additionally, it sought to gather their recommendations for system improvements to guide future development and nationwide implementation. METHODS A parallel mixed methods design was used, integrating both quantitative and qualitative data. A structured online survey was distributed to 54 pharmacies and 190 General Practitioner (GP) surgeries across Norway. The survey included a combination of multiple-choice and open-ended questions. Qualitative responses were analyzed thematically using NVivo, while quantitative data were processed using the built-in analytical tools in Nettskjema.no. RESULTS A total of seventy healthcare professionals participated in the study, revealing seven key themes: training, system and technology, communication and interaction, division of responsibilities, patient safety, time and resource use, and implementation challenges. General Practitioners reported inadequate training and an overwhelming volume of communication, while pharmacists identified issues with system integration and unclear role definitions. Both groups emphasized the need for improved system usability, stronger interprofessional collaboration, and more defined governance structure. CONCLUSIONS While the e-prescribing for multidose drug dispensing system has the potential to improve medication safety and optimized workflows, its success depends on addressing technical inefficiencies, improving user training, and clarifying role responsibilities. Actively involving end users in system development and policy planning is critical for achieving effective national implementation and ensuring integration with broader e-health initiatives, such as the Patient’s Medication List.
- Open Access
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e64899
Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial
Background: Treatment adherence by people with type 2 diabetes (T2D) is overall suboptimal, which can hinder glycemic control. Multiple adherence barriers have been identified, such as the dislike and fear of injections. Several of the recommended antidiabetic drugs are available in oral formulations, which may be a good alternative to injection therapy when possible. However, strict dosing instruction could pose adherence barriers; for example, oral semaglutide requires predose and postdose fasting and restricted water intake at dosing time. Currently, oral semaglutide is the only oral glucagon-like peptide-1 receptor agonist and has only been available for a few years; therefore, limited knowledge exists on adherence to it. Objective: The aim of this study is to investigate the effect of adherence to oral semaglutide dosing instructions on glycemic control in people with T2D who are dysregulated on metformin and optionally a sodium-glucose cotransporter-2 inhibitor and naïve to oral semaglutide. Methods: This prospective, noninterventional, open-label, clinical trial with a duration of 12 weeks will be conducted in Denmark. Eligible participants are adults (aged ≥18 years) with dysregulated T2D (hemoglobin A1c of 53-75 mmol/mol) currently treated with metformin and optionally a sodium-glucose cotransporter-2 inhibitor for whom the next natural step in the treatment is to add an antidiabetic drug to the treatment regimen. Potential participants are recruited through announcements on social media and digital mail sent to their official digital mailbox (e-boks). During the trial, 20 participants will be initiated on oral semaglutide and escalated in dosage in accordance with the label. Information on the participants’ behavior related to the dosing instructions will be collected using the following devices: a smartwatch to track activity and sleep time, a smart pill bottle to track dosing time, a smart bottle to track time and volume of water intake at dosing time, and a smartphone to take a photo of their breakfast to log time of breakfast. Glycemic control will be assessed using an unblinded continuous glucose monitoring sensor that the participants will wear. Participants are asked to report any cases of nausea or vomiting in terms of time of occurrence, duration, and severity. The primary endpoint is change from baseline to end-of-study time-in-range derived from continuous glucose monitoring data. Results: The first participant visit was in April 2024. Three months of high frequency temporal data on adherence behavior will be collected, despite the relatively few expected participants included. Conclusions: Participants may change their behavior due to awareness of being observed. Regardless, the knowledge gained from this trial might be integrated into a decision support system, providing people with diabetes with guidance on how to increase adherence and potentially improving glycemic control. Trial Registration: ClinicalTrials.gov NCT06333080.; https://clinicaltrials.gov/study/NCT06333080 International Registered Report Identifier (IRRID): DERR1-10.2196/64899
- 23 September 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e64899
Open AccessEffect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial
Background: Treatment adherence by people with type 2 diabetes (T2D) is overall suboptimal, which can hinder glycemic control. Multiple adherence barriers have been identified, such as the dislike and fear of injections. Several of the recommended antidiabetic drugs are available in oral formulations, which may be a good alternative to injection therapy when possible. However, strict dosing instruction could pose adherence barriers; for example, oral semaglutide requires predose and postdose fasting and restricted water intake at dosing time. Currently, oral semaglutide is the only oral glucagon-like peptide-1 receptor agonist and has only been available for a few years; therefore, limited knowledge exists on adherence to it. Objective: The aim of this study is to investigate the effect of adherence to oral semaglutide dosing instructions on glycemic control in people with T2D who are dysregulated on metformin and optionally a sodium-glucose cotransporter-2 inhibitor and naïve to oral semaglutide. Methods: This prospective, noninterventional, open-label, clinical trial with a duration of 12 weeks will be conducted in Denmark. Eligible participants are adults (aged ≥18 years) with dysregulated T2D (hemoglobin A1c of 53-75 mmol/mol) currently treated with metformin and optionally a sodium-glucose cotransporter-2 inhibitor for whom the next natural step in the treatment is to add an antidiabetic drug to the treatment regimen. Potential participants are recruited through announcements on social media and digital mail sent to their official digital mailbox (e-boks). During the trial, 20 participants will be initiated on oral semaglutide and escalated in dosage in accordance with the label. Information on the participants’ behavior related to the dosing instructions will be collected using the following devices: a smartwatch to track activity and sleep time, a smart pill bottle to track dosing time, a smart bottle to track time and volume of water intake at dosing time, and a smartphone to take a photo of their breakfast to log time of breakfast. Glycemic control will be assessed using an unblinded continuous glucose monitoring sensor that the participants will wear. Participants are asked to report any cases of nausea or vomiting in terms of time of occurrence, duration, and severity. The primary endpoint is change from baseline to end-of-study time-in-range derived from continuous glucose monitoring data. Results: The first participant visit was in April 2024. Three months of high frequency temporal data on adherence behavior will be collected, despite the relatively few expected participants included. Conclusions: Participants may change their behavior due to awareness of being observed. Regardless, the knowledge gained from this trial might be integrated into a decision support system, providing people with diabetes with guidance on how to increase adherence and potentially improving glycemic control. Trial Registration: ClinicalTrials.gov NCT06333080.; https://clinicaltrials.gov/study/NCT06333080 International Registered Report Identifier (IRRID): DERR1-10.2196/64899
- Open Access
- 8 April 2025
- Published by IOS Press
- Vol. 323, 317-321
Dialysis Nurses’ Experiences with Continuous Glucose Monitoring in Hemodialysis Patients Treated with Insulin
This study examines dialysis nurses’ perspectives on the use of continuous glucose monitoring (CGM) in hemodialysis (HD) patients with insulin-treated diabetes. Through eight semi-structured interviews, nurses highlighted how CGM improved the patients’ and nurses’ ability to monitor patients’ glucose levels, enhancing patient engagement and nursing practices. The nurses emphasized the value of real-time glucose data during dialysis sessions, allowing for timely adjustments and better glycemic control. Despite these advantages, they also noted challenges, including a lack of knowledge regarding CGM technology. Overall, the nurses viewed CGM as a beneficial tool, providing a clearer understanding of patients’ glucose patterns. Furthermore, the findings reveal that CGM fosters better communication and awareness among healthcare professionals and patients, ultimately improving the care provided to insulin-treated HD patients.
- 8 April 2025
- Published by IOS Press
- Vol. 323, 317-321
Open AccessDialysis Nurses’ Experiences with Continuous Glucose Monitoring in Hemodialysis Patients Treated with Insulin
This study examines dialysis nurses’ perspectives on the use of continuous glucose monitoring (CGM) in hemodialysis (HD) patients with insulin-treated diabetes. Through eight semi-structured interviews, nurses highlighted how CGM improved the patients’ and nurses’ ability to monitor patients’ glucose levels, enhancing patient engagement and nursing practices. The nurses emphasized the value of real-time glucose data during dialysis sessions, allowing for timely adjustments and better glycemic control. Despite these advantages, they also noted challenges, including a lack of knowledge regarding CGM technology. Overall, the nurses viewed CGM as a beneficial tool, providing a clearer understanding of patients’ glucose patterns. Furthermore, the findings reveal that CGM fosters better communication and awareness among healthcare professionals and patients, ultimately improving the care provided to insulin-treated HD patients.
- Open Access
- 14 March 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e63230
Contactless Sleep Monitoring for the Detection of Exacerbations in People With Chronic Obstructive Pulmonary Disease: Protocol for a Longitudinal Observational Study
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are one of the main causes of mortality, and early detection of exacerbations is thus essential. Telemedicine solutions have shown promising results for the detection of exacerbations in COPD and have increasingly been used. However, the effect of telemedicine is divergent. According to several studies, respiration rate (RR) increases before, during, and after an exacerbation and the change is measurable with several contactless devices. Despite this, RR is rarely measured, and telemedicine solutions only use wearable devices for measuring RR, even though wearable respiratory monitoring devices have been associated with certain drawbacks. Contactless devices are often used during sleep, as measurements conducted during sleep minimize the risk of disturbance from physical activities. However, the potential of measuring RR and heart rate (HR) during sleep for the detection of exacerbations in COPD remains unclear. Objective: The aim of this observational study is to investigate whether contactless measurement of RR, HR, and sleep stages can be used to detect exacerbations in people with COPD. Methods: An observational study including 50 participants with COPD will be conducted. The participants reside in Aalborg municipality, located in the North Denmark Region. Participants will use a contactless monitor (Sleepiz One+) near their bed during sleep for a period of 4 months. After data collection, descriptive statistics will be used to identify any extremes or variations in RR, HR, or sleep stages in the nights preceding an exacerbation. Correlation analysis will be performed to evaluate the relationship between the number of exacerbations and extremes or variations in RR, HR, or sleep stages. Finally, qualitative interviews will be conducted with 12 participants to explore their experiences of sleeping with the monitor nearby. Results: Recruitment started at the end of April 2024. A total of 12 participants have been recruited, and the remaining participants are expected to be recruited during March and April 2025. Six out of 12 participants have completed the data collection and qualitative interview stages. Overall data collection is expected to be completed by September 2025. The results are expected to provide insight into the potential for identifying extremes or variations in RR, HR, or sleep stages in the days preceding an exacerbation. Additionally, the results are expected to assess the correlation between the number of exacerbations and extremes or variations in RR, HR, and sleep stages. Conclusions: The findings from this study may clarify the possibility of using a contactless monitor to detect exacerbations in COPD. Furthermore, the results may have the potential to improve the ability to predict exacerbations in the future. International Registered Report Identifier (IRRID): DERR1-10.2196/63230
- 14 March 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14 (1) , e63230
Open AccessContactless Sleep Monitoring for the Detection of Exacerbations in People With Chronic Obstructive Pulmonary Disease: Protocol for a Longitudinal Observational Study
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are one of the main causes of mortality, and early detection of exacerbations is thus essential. Telemedicine solutions have shown promising results for the detection of exacerbations in COPD and have increasingly been used. However, the effect of telemedicine is divergent. According to several studies, respiration rate (RR) increases before, during, and after an exacerbation and the change is measurable with several contactless devices. Despite this, RR is rarely measured, and telemedicine solutions only use wearable devices for measuring RR, even though wearable respiratory monitoring devices have been associated with certain drawbacks. Contactless devices are often used during sleep, as measurements conducted during sleep minimize the risk of disturbance from physical activities. However, the potential of measuring RR and heart rate (HR) during sleep for the detection of exacerbations in COPD remains unclear. Objective: The aim of this observational study is to investigate whether contactless measurement of RR, HR, and sleep stages can be used to detect exacerbations in people with COPD. Methods: An observational study including 50 participants with COPD will be conducted. The participants reside in Aalborg municipality, located in the North Denmark Region. Participants will use a contactless monitor (Sleepiz One+) near their bed during sleep for a period of 4 months. After data collection, descriptive statistics will be used to identify any extremes or variations in RR, HR, or sleep stages in the nights preceding an exacerbation. Correlation analysis will be performed to evaluate the relationship between the number of exacerbations and extremes or variations in RR, HR, or sleep stages. Finally, qualitative interviews will be conducted with 12 participants to explore their experiences of sleeping with the monitor nearby. Results: Recruitment started at the end of April 2024. A total of 12 participants have been recruited, and the remaining participants are expected to be recruited during March and April 2025. Six out of 12 participants have completed the data collection and qualitative interview stages. Overall data collection is expected to be completed by September 2025. The results are expected to provide insight into the potential for identifying extremes or variations in RR, HR, or sleep stages in the days preceding an exacerbation. Additionally, the results are expected to assess the correlation between the number of exacerbations and extremes or variations in RR, HR, and sleep stages. Conclusions: The findings from this study may clarify the possibility of using a contactless monitor to detect exacerbations in COPD. Furthermore, the results may have the potential to improve the ability to predict exacerbations in the future. International Registered Report Identifier (IRRID): DERR1-10.2196/63230
- Open Access
- 24 December 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 5 (1) , 1
Explainable Machine Learning-Based Approach to Identify People at Risk of Diabetes Using Physical Activity Monitoring
Objective: This study aimed to investigate the utilization of patterns derived from physical activity monitoring (PAM) for the identification of individuals at risk of type 2 diabetes mellitus (T2DM) through an at-home screening approach employing machine learning techniques. Methods: Data from the 2011–2014 National Health and Nutrition Examination Survey (NHANES) were scrutinized, focusing on the PAM component. The primary objective involved the identification of diabetes, characterized by an HbA1c ≥ 6.5% (48 mmol/mol), while the secondary objective included individuals with prediabetes, defined by an HbA1c ≥ 5.7% (39 mmol/mol). Features derived from PAM, along with age, were utilized as inputs for an XGBoost classification model. SHapley Additive exPlanations (SHAP) was employed to enhance the interpretability of the models. Results: The study included 7532 subjects with both PAM and HbA1c data. The model, which solely included PAM features, had a test dataset ROC-AUC of 0.74 (95% CI = 0.72–0.76). When integrating the PAM features with age, the model’s ROC-AUC increased to 0.79 (95% CI = 0.78–0.80) in the test dataset. When addressing the secondary target of prediabetes, the XGBoost model exhibited a test dataset ROC-AUC of 0.80 [95% CI; 0.79–0.81]. Conclusions: The objective quantification of physical activity through PAM yields valuable information that can be employed in the identification of individuals with undiagnosed diabetes and prediabetes.
- 24 December 2024
- Published by MDPI AG in BioMedInformatics
- Vol. 5 (1) , 1
Open AccessExplainable Machine Learning-Based Approach to Identify People at Risk of Diabetes Using Physical Activity Monitoring
Objective: This study aimed to investigate the utilization of patterns derived from physical activity monitoring (PAM) for the identification of individuals at risk of type 2 diabetes mellitus (T2DM) through an at-home screening approach employing machine learning techniques. Methods: Data from the 2011–2014 National Health and Nutrition Examination Survey (NHANES) were scrutinized, focusing on the PAM component. The primary objective involved the identification of diabetes, characterized by an HbA1c ≥ 6.5% (48 mmol/mol), while the secondary objective included individuals with prediabetes, defined by an HbA1c ≥ 5.7% (39 mmol/mol). Features derived from PAM, along with age, were utilized as inputs for an XGBoost classification model. SHapley Additive exPlanations (SHAP) was employed to enhance the interpretability of the models. Results: The study included 7532 subjects with both PAM and HbA1c data. The model, which solely included PAM features, had a test dataset ROC-AUC of 0.74 (95% CI = 0.72–0.76). When integrating the PAM features with age, the model’s ROC-AUC increased to 0.79 (95% CI = 0.78–0.80) in the test dataset. When addressing the secondary target of prediabetes, the XGBoost model exhibited a test dataset ROC-AUC of 0.80 [95% CI; 0.79–0.81]. Conclusions: The objective quantification of physical activity through PAM yields valuable information that can be employed in the identification of individuals with undiagnosed diabetes and prediabetes.
- Open Access
- 9 December 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 195, 105758
Modeling the fasting blood glucose response to basal insulin adjustment in type 2 diabetes: An explainable machine learning approach on real-world data
- 9 December 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 195, 105758
Open AccessModeling the fasting blood glucose response to basal insulin adjustment in type 2 diabetes: An explainable machine learning approach on real-world data
- Open Access
- 22 August 2024
- Published by IOS Press
- Vol. 316, 1763-1764
Collaborative Care Interventions for Patients with Multimorbidity: Protocol for a Systematic Review and Meta-Analysis with Preliminary Results
Collaborative care interventions have been proposed as a promising strategy for the management of patients with multimorbidity. This systematic review and meta-analysis aims to assess the effectiveness of collaborative care interventions for adult patients with multimorbidity. Furthermore, a meta-regression analysis is planned to determine if certain participant or intervention characteristics can explain variance in effect.
- 22 August 2024
- Published by IOS Press
- Vol. 316, 1763-1764
Open AccessCollaborative Care Interventions for Patients with Multimorbidity: Protocol for a Systematic Review and Meta-Analysis with Preliminary Results
Collaborative care interventions have been proposed as a promising strategy for the management of patients with multimorbidity. This systematic review and meta-analysis aims to assess the effectiveness of collaborative care interventions for adult patients with multimorbidity. Furthermore, a meta-regression analysis is planned to determine if certain participant or intervention characteristics can explain variance in effect.
- Open Access
- 22 August 2024
- Published by IOS Press
- Vol. 316, 73-77
Detailed Insights into Basal Insulin Adherence in People with Type 2 Diabetes Using a Data-Driven Assessment Method
Introduction: Basal insulin non-adherence is a challenge in people with type 2 diabetes (T2D). Methods: Using injection data recorded by a connected insulin pen, we employed a novel three-step methodology to assess three aspects of adherence (overall adherence, adherence distribution, and dose deviation) in individuals with insulin-treated T2D undergoing telemonitoring. Results: Among participants, 52% were considered overall adherent. However, deviations from the recommended dose were observed in all participants, with increased and reduced doses being the predominant forms of non-adherence. Conclusions: Our study underscores the prevalence of basal insulin dosing irregularities in individuals with insulin-treated T2D undergoing telemonitoring.
- 22 August 2024
- Published by IOS Press
- Vol. 316, 73-77
Open AccessDetailed Insights into Basal Insulin Adherence in People with Type 2 Diabetes Using a Data-Driven Assessment Method
Introduction: Basal insulin non-adherence is a challenge in people with type 2 diabetes (T2D). Methods: Using injection data recorded by a connected insulin pen, we employed a novel three-step methodology to assess three aspects of adherence (overall adherence, adherence distribution, and dose deviation) in individuals with insulin-treated T2D undergoing telemonitoring. Results: Among participants, 52% were considered overall adherent. However, deviations from the recommended dose were observed in all participants, with increased and reduced doses being the predominant forms of non-adherence. Conclusions: Our study underscores the prevalence of basal insulin dosing irregularities in individuals with insulin-treated T2D undergoing telemonitoring.